PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#pharmaceutical quality ×

UPDATED
Regulatorische Updates
24. Aug. 2026•1 Min. Lesezeit
FDA Recall: Foreign Substances and Heavy Metals Detected in Product
FDA has recalled a product after routine stability testing revealed visible foreign substances, including heavy metals such as chromium and titanium, and inactive components.
UPDATED
Regulatorische Updates
23. Aug. 2026•1 Min. Lesezeit
Cadila Pharmaceuticals reports barcode error on Mirtazapine 30mg tablets
Cadila Pharmaceuticals notified the MHRA of an incorrect EAN barcode on cartons of a batch of Mirtazapine 30mg film-coated tablets distributed by Crescent Pharma.